We are once again supporting the NBIC Biofilm Week 2022 campaign, highlighting research to prevent, detect, manage, and engineer biofilms.
Perfectus Biomed Group, now part of NAMSA, are thrilled to take this opportunity to launch our Biofilm Spotlight Interview Series....
In order to ensure medical devices are safe for use, regulatory bodies require manufacturers to demonstrate adequate inactivation and removal of viruses. Perfectus Biomed, now part of NAMSA, can help you with this key validation step.
A crucial element in the product...
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK founded laboratory, providing customized microbiological services.
“Perfectus Biomed Group...
What is Monkeypox?
On the 23rd July 2022, the World Health Organisation declared the spread of monkeypox as a public health emergency of international concern. Countries in Europe have recorded high cases, but there have also been reports in the US, Canada, Australia,...
What is ISO 10993?
ISO 10993 sets out a series of standards for evaluating the biocompatibility of medical devices to manage biological risk. ISO defines biocompatibility as the “ability of a medical device or material to perform with an appropriate host response in a...
We are thrilled to announce that we have recently received UKAS ISO 17025 accreditation for our ex vivo tissue Burn Wound Model. This latest accreditation adds to our impressive list of accredited biofilm methods, both in vitro and ex vivo. Well done to our fantastic,...
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK founded laboratory, providing customized microbiological services.
“Perfectus Biomed Group...
What is ISO 10993?
ISO 10993 sets out a series of standards for evaluating the biocompatibility of medical devices to manage biological risk. ISO defines biocompatibility as the “ability of a medical device or material to perform with an appropriate host response in a...
We are thrilled to announce that we have recently received UKAS ISO 17025 accreditation for our ex vivo tissue Burn Wound Model. This latest accreditation adds to our impressive list of accredited biofilm methods, both in vitro and ex vivo. Well done to our fantastic,...